{"id":50950,"date":"2022-11-16T16:02:39","date_gmt":"2022-11-16T15:02:39","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\/"},"modified":"2022-11-16T16:02:39","modified_gmt":"2022-11-16T15:02:39","slug":"escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\/","title":{"rendered":"Escient Pharmaceuticals Strengthens Leadership Team with Key New Hires"},"content":{"rendered":"
\n

SAN DIEGO–(BUSINESS WIRE)–Escient Pharmaceuticals, a clinical-stage company advancing novel small molecule therapeutics for the potential treatment of a broad range of neurosensory-inflammatory disorders, today announced the addition of three key new members to its leadership team.\n<\/p>\n

<\/a><\/p>\n

\nAaron Mishel has joined the company as Chief Financial Officer, David Houck as Vice President of CMC (Chemistry, Manufacturing & Controls), and Greg Balani as Director of Business Development.\n<\/p>\n

\n\u201cWe are pleased to welcome Aaron, David, and Greg to Escient Pharmaceuticals\u201d said CEO Joshua Grass. \u201cThese new hires will help drive our growth and transition to an innovative clinical development company. In 2023 we plan to initiate five clinical trials, all while retaining our leading drug discovery capabilities. Our pipeline includes two novel, first-in-class small molecule product candidates to treat an array of neurosensory-inflammatory diseases: EP262 (MRGPRX2 antagonist) for chronic spontaneous urticaria (CSU), chronic inducible urticaria (CindU) and atopic dermatitis (AD) and EP547 (MRGPRX4 antagonist) for cholestatic pruritus.\u201d\n<\/p>\n

\nAaron Mishel \u2013 Chief Financial Officer\n<\/p>\n

\nMr. Mishel brings over twenty years of experience in the life sciences and financial services sectors to the company. Prior to Escient, he served as CFO or head of finance for several venture-backed private healthcare companies including GenEdit, Magnetic Insight, and Modis Therapeutics. Previously, he worked in business and corporate development at BioMarin Pharmaceutical, spent six years in Equity Research at Deutsche Bank and Thomas Weisel Partners, and held positions of increasing responsibility in finance at CV Therapeutics. He holds a B.S. in Biomedical Engineering and a B.A. in Economics from Brown University and an MBA from the Stanford Graduate School of Business.\n<\/p>\n

\nDr. David Houck \u2013 Vice President of CMC (Chemistry, Manufacturing & Controls)\n<\/p>\n

\nDr. Houck has over 35 years of biopharmaceutical industry experience in regulatory affairs, formulation development, manufacturing, and quality control of pharmaceutical products. Previously, Dr. Houck was Chief Development Officer at Aptinyx Inc. and held various senior R&D positions at Merck, Sterling Winthrop, Sanofi, OSI Pharmaceuticals, and Scynexis. He has led CMC programs for a variety of dosage forms which contributed to the advancement of several clinical and marketed pharmaceutical products. He was trained in biochemistry and medicinal chemistry, completed degrees at Alma College (B.S.), Purdue University (M.S.), and Ohio State University (Ph.D.), and served as a postdoctoral fellow at the Los Alamos National Laboratory.\n<\/p>\n

\nGreg Balani \u2013 Director of Business Development\n<\/p>\n

\nPrior to Escient, Mr. Balani served as Director of Business Development at Zogenix, where he was instrumental in the company\u2019s sale to UCB. Before Zogenix, Mr. Balani held positions of increasing responsibility at Bayer in the U.S. Business Development & Licensing and the Global Mergers, Acquisitions & Licensing groups, where he worked on in-licensing assets, acquisitions, and asset divestitures. Prior to Bayer, he worked as a management consultant at Huron within its Corporate and Operational division. He received a PharmD from the University of California San Francisco and a B.S. from DePaul University.\n<\/p>\n

\nAbout Escient Pharmaceuticals\n<\/p>\n

\nEscient Pharmaceuticals is a clinical-stage company focused on developing novel therapeutics to address a broad range of neurosensory-inflammatory disorders. The company\u2019s pipeline includes two first-in-class small molecule antagonists targeting MRGPRX2 for the treatment of various mast cell mediated disorders and MRGPRX4 for cholestatic pruritus. Based in San Diego, California, Escient is led by an experienced management and scientific team and funded by top-tier life science investors.\n<\/p>\n

\nVisit www.escientpharma.com<\/a> to learn more.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nAaron Mishel
\n
Chief Financial Officer
\n
Escient Pharmaceuticals, Inc.
\n
info@escientpharma.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN DIEGO–(BUSINESS WIRE)–Escient Pharmaceuticals, a clinical-stage company advancing novel small molecule therapeutics for the potential treatment of a broad range of neurosensory-inflammatory disorders, today announced the addition of three key new members to its leadership team. Aaron Mishel has joined the company as Chief Financial Officer, David Houck as Vice President of CMC (Chemistry, Manufacturing … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50950","6":"format-standard","7":"category-industry"},"yoast_head":"\nEscient Pharmaceuticals Strengthens Leadership Team with Key New Hires - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Escient Pharmaceuticals Strengthens Leadership Team with Key New Hires - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO–(BUSINESS WIRE)–Escient Pharmaceuticals, a clinical-stage company advancing novel small molecule therapeutics for the potential treatment of a broad range of neurosensory-inflammatory disorders, today announced the addition of three key new members to its leadership team. Aaron Mishel has joined the company as Chief Financial Officer, David Houck as Vice President of CMC (Chemistry, Manufacturing ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-16T15:02:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221116005423\/en\/1634054\/21\/Escient_Logo_%28white_background%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Escient Pharmaceuticals Strengthens Leadership Team with Key New Hires\",\"datePublished\":\"2022-11-16T15:02:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\\\/\"},\"wordCount\":584,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221116005423\\\/en\\\/1634054\\\/21\\\/Escient_Logo_%28white_background%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\\\/\",\"name\":\"Escient Pharmaceuticals Strengthens Leadership Team with Key New Hires - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221116005423\\\/en\\\/1634054\\\/21\\\/Escient_Logo_%28white_background%29.jpg\",\"datePublished\":\"2022-11-16T15:02:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221116005423\\\/en\\\/1634054\\\/21\\\/Escient_Logo_%28white_background%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221116005423\\\/en\\\/1634054\\\/21\\\/Escient_Logo_%28white_background%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Escient Pharmaceuticals Strengthens Leadership Team with Key New Hires\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Escient Pharmaceuticals Strengthens Leadership Team with Key New Hires - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\/","og_locale":"en_US","og_type":"article","og_title":"Escient Pharmaceuticals Strengthens Leadership Team with Key New Hires - Pharma Trend","og_description":"SAN DIEGO–(BUSINESS WIRE)–Escient Pharmaceuticals, a clinical-stage company advancing novel small molecule therapeutics for the potential treatment of a broad range of neurosensory-inflammatory disorders, today announced the addition of three key new members to its leadership team. Aaron Mishel has joined the company as Chief Financial Officer, David Houck as Vice President of CMC (Chemistry, Manufacturing ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-16T15:02:39+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221116005423\/en\/1634054\/21\/Escient_Logo_%28white_background%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Escient Pharmaceuticals Strengthens Leadership Team with Key New Hires","datePublished":"2022-11-16T15:02:39+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\/"},"wordCount":584,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221116005423\/en\/1634054\/21\/Escient_Logo_%28white_background%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\/","url":"https:\/\/pharma-trend.com\/en\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\/","name":"Escient Pharmaceuticals Strengthens Leadership Team with Key New Hires - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221116005423\/en\/1634054\/21\/Escient_Logo_%28white_background%29.jpg","datePublished":"2022-11-16T15:02:39+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221116005423\/en\/1634054\/21\/Escient_Logo_%28white_background%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221116005423\/en\/1634054\/21\/Escient_Logo_%28white_background%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/escient-pharmaceuticals-strengthens-leadership-team-with-key-new-hires\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Escient Pharmaceuticals Strengthens Leadership Team with Key New Hires"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50950","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50950"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50950\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50950"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50950"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50950"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}